Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/2/2025

Testosterone Replacement Therapy Guidelines

Clinical Considerations

  • The American College of Clinical Nutrition recommends testosterone substitution to restore muscle mass in HIV-positive patients with testosterone deficiency 1
  • Randomized placebo-controlled trials show positive effects of testosterone substitution on fat-free mass, muscle mass, and quality of life in patients with wasting and low testosterone 1
  • In women with HIV wasting who have low testosterone, supplementation shows some positive effects on muscle mass strength but no significant weight gain, according to Praxis Medical Insights 2
  • The Endocrine Society recommends aiming to achieve total testosterone levels in the middle tertile of the normal reference range (450-600 ng/dL) during testosterone therapy 3

Monitoring and Safety

  • The American Gastroenterological Association recommends testing testosterone levels 2-3 months after treatment initiation and after any dose change 4, 3
  • The American Urological Association advises patients that the current scientific literature does not definitively demonstrate that testosterone therapy increases cardiovascular risk 3
  • Lifestyle modifications such as weight loss and increased physical activity should be recommended alongside testosterone therapy, according to The Journal of Urology 3
  • The American Gastroenterological Association prefers transdermal testosterone preparations (gel, patch) for convenience and more stable testosterone levels compared to injections 4, 5

Caveats and Considerations

  • The FDA requires labeling changes regarding possible increased risk of heart attack and stroke with testosterone use for age-related hypogonadism, as reported in Gastroenterology 4
  • Some evidence suggests testosterone injections may be associated with greater cardiovascular risk than gels, possibly due to fluctuating testosterone levels, according to Gastroenterology 4
  • Testosterone therapy is not currently licensed for use in HIV wasting in women in Europe, as stated in Praxis Medical Insights 2
  • Long-term follow-up is needed for patients on testosterone therapy to monitor for potential adverse effects, recommends Clinical Nutrition 1